Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic or Recurrent Gynecological Tumors”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)UnknownNCT05028504
What this trial is testing

A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer

Who this might be right for
Gynecological Cancer
Sichuan Cancer Hospital and Research Institute 86
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Testing effectiveness (Phase 2)Ended earlyNCT01184053
What this trial is testing

Trisenox® in Women With Metastatic Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06131450
What this trial is testing

BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

Who this might be right for
Gynecological Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 138
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Early research (Phase 1)UnknownNCT05238818
What this trial is testing

Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors

Who this might be right for
Metastatic or Recurrent Gynecological Tumors
XinWu 36
Early research (Phase 1)Study completedNCT00268918
What this trial is testing

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+3 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Looking for participantsNCT06769152
What this trial is testing

A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors

Who this might be right for
Cervical CancerOvarian Cancer
Shanghai Henlius Biotech 190
Testing effectiveness (Phase 2)Looking for participantsNCT05990803
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies

Who this might be right for
Cervical Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04395079
What this trial is testing

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Who this might be right for
Metastatic Malignant Female Reproductive System NeoplasmPlatinum-Resistant Malignant Female Reproductive System NeoplasmRecurrent Malignant Female Reproductive System Neoplasm+1 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
9